CD44 and breast carcinoma: In breast cancer, the ESA+CD44+CD24− population is considered as stem-cell-like cell (or stemness) population because it has high aggressiveness, tumorigenicity, and self-renewal capacity [27,28] and is closely involved in distant metastasis [29,30,31].